David Glenn (CIK 1606256) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-11). Recent activity: Buy PAHC (30,000 shares), Sell PAHC (12,528 shares), Buy PAHC (4,845 shares), Buy PAHC (30,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-11 | PHIBRO ANIMAL HEALTH CORP (PAHC) | Chief Financial Officer | Buy | 30,000 | $0 |
| 2026-02-11 | PHIBRO ANIMAL HEALTH CORP (PAHC) | Chief Financial Officer | Sell | 12,528 | $646,821 |
| 2025-08-19 | PHIBRO ANIMAL HEALTH CORP (PAHC) | Chief Financial Officer | Buy | 4,845 | $0 |
| 2025-02-11 | PHIBRO ANIMAL HEALTH CORP (PAHC) | Chief Financial Officer | Buy | 30,000 | $0 |
Source: SEC Form 4 filings · as of 2026-02-11